About this course

  • Released: 10/22/2013
  • Expires: 10/22/2016

 

 

ENCEPHALITIS AND GABAB RECEPTOR ANTIBODIES: NOVEL FINDINGS IN A NEW CASE SERIES OF 20 PATIENTS

LEARNING OBJECTIVES:

Upon completion of the article by Hoftberger et al, the participant should be able to:

  • Recognize antibodies to the GABAB receptor as one of the causes of autoimmune encephalitis
  • Discuss the clinical symptoms and neoplasm associated with GABAB receptor autoimmune encephalitis
  • Discuss the response to treatment in patients with GABAB receptor autoimmune encephalitis

CORE COMPETENCIES:

The article by Hoftberger et alcovers the following core competency:

  • Medical Knowledge

 

QUALITY IMPROVEMENT IN NEUROLOGY: DEMENTIA MANAGEMENT QUALITY MEASURES

LEARNING OBJECTIVES:

Upon completion of the article by Odenheimer et al, the participant should be able to:

  • Recognize the need for overall improvements in the quality of care for patients with dementia
  • Discuss the importance of quality measures to evaluate and track dementia care in clinical settings
  • List the quality measures for comprehensive, integrated care of dementia developed by this interdisciplinary group

CORE COMPETENCIES:

The article by Odenheimer et alcovers the following core competency:

  • Medical Knowledge
  • Systems-Based Practice

AUTHOR DISCLOSURES

Refer to listing above the references in each article.

THIS PAGE IS REQUIRED READING BEFORE BEGINNING ALL ACCME-ACCREDITED COURSES

ACCREDITATION STATEMENT

The American Academy of Neurology designates that participants will receive 1.5 AMA PRA Category 1 CME credits if both CME courses for the issue are completed. Physicians should only claim credit commensurate with the extent of their participation in the activity. The American Academy of Neurology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

MISSION STATEMENT/PROGRAM OBJECTIVES

After evaluating a specific article published in Neurology, participants in the CME activity should be able to demonstrate an increase in, or affirmation of, their knowledge of clinical medicine. Participants should be able to evaluate the appropriateness of the clinical information as it applies to the provision of patient care.

PARTICIPANTS

This program is designed for physicians who are involved in providing patient care and who wish to advance their current knowledge of clinical medicine.

CREDITS

The American Academy of Neurology designates that participants will receive 1.5 AMA PRA Category 1 CME credits if both CME courses for the issue are completed.

The American Academy of Neurology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to sponsor continuing medical education for physicians.

DISCLOSURES

Steven Lewis, MD receives a stipend in his editorial capacity for Neurology and as an Associate Editor for Continuum: Lifelong Learning in Neurology; has received royalties for the books Field Guide to the Neurologic Examination and Neurology for the Non-Neurologist; and anticipates receiving royalties for the book Neurologic Disorders due to Systemic Disease. James WM Owens Jr. MD, PhD receives royalties from UpToDate, Waltham, MA; grant support from NIH (PI, K08NS054882); and a stipend in his editorial capacity for Neurology.

COMMERCIAL SUPPORT

This CME program receives no commercial support.

ACCME